A detailed history of Ndvr, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Ndvr, Inc. holds 279 shares of LLY stock, worth $214,205. This represents 0.25% of its overall portfolio holdings.

Number of Shares
279
Previous 303 7.92%
Holding current value
$214,205
Previous $274 Million 10.73%
% of portfolio
0.25%
Previous 0.29%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$772.14 - $960.02 $18,531 - $23,040
-24 Reduced 7.92%
279 $245 Million
Q2 2024

Aug 09, 2024

BUY
$724.87 - $909.04 $219,635 - $275,439
303 New
303 $274 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ndvr, Inc. Portfolio

Follow Ndvr, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ndvr, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ndvr, Inc. with notifications on news.